Home > Financial Ratios > SOTAC PHARMACEUTICALS

SOTAC PHARMACEUTICALS
EV/Core EBITDA

    Back to All Ratios
COMMUNITY POLL
for SOTAC PHARMACEUTICALS
Please provide your vote to see the results

SOTAC PHARMACEUTICALS Last 5 Year EV/Core EBITDA History

[Consolidated]

Mar2025Mar2024Mar2023Mar2022Mar2021
   EV/Core EBITDA(x) 9.8917.632.661.5112.26

What is the latest EV/Core EBITDA ratio of SOTAC PHARMACEUTICALS ?

The latest EV/Core EBITDA ratio of SOTAC PHARMACEUTICALS is 9.89 based on Mar2025 Consolidated results.
Year EV/Core EBITDA
Mar20259.89
Mar202417.63
Mar20232.66
Mar20221.51
Mar202112.26

How is EV/Core EBITDA of SOTAC PHARMACEUTICALS Trending?

Years EV/Core EBITDA % Change
Mar2025 9.89
-43.90
Mar2024 17.63
562.78
Mar2023 2.66
76.16
Mar2022 1.51
-87.68
Mar2021 12.26 -

Other Financial Ratios of SOTAC PHARMACEUTICALS


Compare EV/Core EBITDA ratio of peers of SOTAC PHARMACEUTICALS

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
SOTAC PHARMACEUTICALS ₹116.6 Cr -14.5% -23% -26.1% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹391,488.0 Cr -2.1% -7.7% -9.7% Stock Analytics
DIVIS LABORATORIES ₹159,415.0 Cr -2.6% -6.8% 1.5% Stock Analytics
TORRENT PHARMACEUTICALS ₹132,906.0 Cr 0.1% 5.5% 25.3% Stock Analytics
CIPLA ₹106,210.0 Cr -1.9% -9.3% -5.1% Stock Analytics
DR REDDYS LABORATORIES ₹103,089.0 Cr 3.5% -5.2% -11.8% Stock Analytics


SOTAC PHARMACEUTICALS Share Price vs Sensex


Share Price Returns(%) 1 Week 1 Month 1 Year
SOTAC PHARMACEUTICALS

-14.5%

-23%

-26.1%

SENSEX

-2.4%

-4.7%

6.4%


You may also like the below Video Courses